Previous Close | 9.33 |
Open | 9.27 |
Bid | 9.24 x 0 |
Ask | 9.26 x 0 |
Day's Range | 9.17 - 9.28 |
52 Week Range | 5.75 - 9.52 |
Volume | |
Avg. Volume | 157,673 |
Market Cap | 772.07M |
Beta (5Y Monthly) | 1.27 |
PE Ratio (TTM) | 13.60 |
EPS (TTM) | 0.68 |
Earnings Date | Nov 12, 2024 |
Forward Dividend & Yield | 0.48 (5.14%) |
Ex-Dividend Date | Sept 27, 2024 |
1y Target Est | 9.67 |
MARKHAM, Ontario, Oct. 04, 2024 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced today that it plans to release its financial results for the third quarter of 2024 after market close on Tuesday, November 12, 2024. A conference call hosted by Michael Guerriere, President and Chief Executive Officer, and David Bacon, Senior Vice President and Chief Financial Officer, will be held on Wednesday, November 13, 2024, at 11:30 a.m. (ET) to discuss the results. T
As the Canadian market continues to ride a wave of optimism fueled by recent rate cuts from the U.S. Federal Reserve and enthusiasm around AI, the TSX has reached all-time highs, mirroring gains seen in U.S. indices like the S&P 500. Despite potential volatility from upcoming U.S. elections, investors remain focused on fundamental economic indicators and corporate earnings growth. In this favorable environment, identifying undiscovered gems in Canada's stock market can offer significant...
As markets continue to ride a wave of optimism fueled by the U.S. Fed's recent rate cut and ongoing AI enthusiasm, Canadian stocks have also benefited, with the TSX reaching all-time highs last week. This positive market sentiment creates an opportune environment for identifying high-potential small-cap stocks that may be overlooked by mainstream investors.